Zimmer Biomet Holdings Inc
NYSE:ZBH
Zimmer Biomet Holdings Inc
Net Income (Common)
Zimmer Biomet Holdings Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Net Income (Common)
$903.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
4%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
19%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$13.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
|
Zimmer Biomet Holdings Inc
Glance View
Zimmer Biomet Holdings Inc. stands as a prominent player in the medical device industry, specializing in musculoskeletal healthcare. Emerging from a rich legacy that dates back to its origins in the early 20th century, the company has carved out its niche by innovating in the orthopedic reconstruction sector. Zimmer Biomet operates primarily through designing, manufacturing, and marketing a comprehensive range of orthopedic products, which include joint replacement implants, such as knees, hips, and shoulders, as well as products used for fracture fixation and bone growth stimulation. The innovative edge of Zimmer Biomet lies in its commitment to improving patient outcomes and enhancing the quality of life through advanced surgical and robotic technologies. The company invests significantly in R&D to maintain its competitive edge, constantly pushing the boundaries in personalized solutions and minimally invasive surgery. The company generates revenue by selling its orthopedic and surgical products directly to hospitals, surgical centers, and healthcare providers worldwide. Zimmer Biomet's business model is heavily reliant on the relationships it builds with orthopedic surgeons and healthcare institutions, positioning itself as an essential partner in delivering sophisticated solutions for musculoskeletal health. By focusing on comprehensive, integrated solutions, Zimmer Biomet not only addresses the immediate surgical needs but also engages with the continuum of care in rehabilitation and patient recovery. The company’s strategic acquisitions, sophisticated product pipeline, and global market presence enable it to capture a significant share of the medical device market, ensuring its role as a stalwart in transforming the future of healthcare.
See Also
What is Zimmer Biomet Holdings Inc's Net Income (Common)?
Net Income (Common)
903.8m
USD
Based on the financial report for Dec 31, 2024, Zimmer Biomet Holdings Inc's Net Income (Common) amounts to 903.8m USD.
What is Zimmer Biomet Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
2%
Over the last year, the Net Income (Common) growth was -12%. The average annual Net Income (Common) growth rates for Zimmer Biomet Holdings Inc have been 31% over the past three years , -4% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet